In addition to SIX1, previous works dealing with the effects of myogenic regulatory factors on muscle cancer have discovered their capacity to stimulate cancer cell differentiation and deregulation of the cell cycle leading to tumor growth regression (Tenente et al, 2017). This evidence concerns the gene SIX1 and muscle cancer.